临床肿瘤学杂志

• 论著 • 上一篇    下一篇

Micro-PET在膈下逐瘀汤抑制肝细胞癌研究中的应用

蔡刚明1,赵韬2,张汀荣2,顾晓波1,黄洪波1   

  1. 1 214063江苏无锡江苏省原子医学研究所卫生部核医学重点实验室 江苏省分子核医学重点实验室2 214400 江阴市人民医院肿瘤科
  • 收稿日期:2017-05-24 修回日期:2017-08-11 出版日期:2017-10-30 发布日期:2017-10-30
  • 通讯作者: 赵韬

Evaluation of hepatocellular carcinoma-bearing mice treated by Gexia Zhuyutang with micro-PET imaging technology

CAI Gangming,ZHAO Tao,ZHANG Tingrong,GU Xiaobo,HUANG Hongbo.   

  1. Key Laboratory of Nuclear Medicine,Ministry of Health,Jiangsu Key Laboratory of Molecular Nuclear Medicine,Jiangsu Institute of Nuclear Medicine,Wuxi 214063,China
  • Received:2017-05-24 Revised:2017-08-11 Online:2017-10-30 Published:2017-10-30
  • Contact: ZHAO Tao

摘要: 目的 采用micro-PET显像技术评判中药复方膈下逐淤汤对荷肝细胞癌裸鼠的抑制作用。方法20周龄健康裸鼠12只,随机分为给药组与对照组(n=6),皮下接种人肝癌细胞Bel7402建立荷瘤模型。接种1周后每日灌胃膈下逐淤汤0.3 ml,对照组给予等体积生理盐水,连续给药60 d。待肿瘤长至约5 mm时测量肿瘤体积,每周2次,计算瘤体积大小和抑瘤率并绘制肿瘤生长曲线。给药24、60 d后分别行18F-FDG、18F-RGD micro-PET扫描各一次,测定肿瘤组织摄取量、标准摄取值(SUV)及肿瘤/肌肉靶本比(T/NT)。结果 接种24 d后,肿瘤生长至5 mm,给药组瘤体积(74.8 mm3)小于对照组(78.3 mm3)。18F-FDG micro-PET扫描给药组的肿瘤组织摄取量、SUVmean和T/NT分别为(5.54±1.59)%ID/g、0.93±0.20和8.20±2.52,略小于对照组(5.92±1.23)%ID/g、1.00±0.19和8.71±2.36 (P>0.05)。18F-RGD micro-PET扫描给药组的肿瘤组织摄取量、SUV和T/NT分别为(4.08±0.64)%ID/g、0.75±0.08和6.91±0.72,略小于对照组(4.61±1.08)%ID/g、0.87±0.16和7.00±1.40(P>0.05)。接种60 d后,给药组和对照组的肿瘤体积分别增长至1854.4 mm3和1462.9 mm3。18F-FDG micro-PET扫描给药组的肿瘤组织摄取量、SUV和T/NT分别为(3.56±0.54)%ID/g、0.70±0.09和4.91±0.92(n=5),大于对照组的3.28%ID/g、0.60和3.98(n=1)。18F-RGD micro-PET扫描给药组的肿瘤组织摄取量、SUV和T/NT分别为(2.19±0.16)%ID/g、0.51±0.04和4.15±0.57(n=4)。给药组和对照组的肿瘤重量分别为(1.93±0.95)g(n=5)和1.69 g(n=1),抑瘤率为-14.76%。给药组的中位生存时间为60 d,长于对照组的40.5 d,差异有统计学意义(P<0.05)。结论 膈下逐淤汤可能通过抑制葡萄糖的吸收和新生血管的生成来延长荷肝细胞癌裸鼠的生存时间。Micro-PET能动态地定量分析活体动物模型的生理、生化变化,可用于评价抗肿瘤药物的体内疗效。

Abstract: Objective Using micro-PET imaging technology to evaluate the effect of hepatocellular carcinoma(HCC)-bearing mice treated by traditional Chinese compound medicine(Gexia Zhuyutang). Methods Tweleve healthy nude mice of 20 weeks were randomly divided into intervention group and control group. Each mouse was subcutaneous inoculated of human HCC cells to establish Bel-7402 tumor-burdened model. After 1 week, each mouse in intervention group was gavaged by Gexia Zhuyutang 0.3 ml every day, while mice in the control group were given by 0.3 ml normal saline for two months. We then calculated the tumor size and inhibitory rate twice a week and drawed the tumor growth curve. All the tumor-bearing mice received 18F-FDG/18F-RGD micro-PET imaging at the 24 and 60 days.We detected the tissue absorption, standard uptake value(SUV) and tumor to muscle ratio(T/NT). Results Twenty-four days after inoculation, the average volume of intervention group (74.8 mm3) was less than the control group (78.3 mm3), but the difference was not statistically significant(P>0.05). The tissue absorption, SUV and T/NT of intervention group were respectively (5.54±1.59)%ID/g, 0.93±0.20 and 8.20±2.52 by 18F-FDG micro-PET, slightly smaller than the control group which were (5.92±1.23)%ID/g, 1.00±0.19 and 8.71±2.36(P>0.05). The tissue absorption, SUV and T/NT of intervention group were (4.08±0.64)%ID/g, 0.75±0.08 and 6.91±0.72 by 18F-RGD micro-PET, slightly smaller than the control group which were (4.61±1.08)%ID/g、0.87±0.16 and 7.00±1.40(P>0.05). At 60 days after inoculation, the average volume of intervention group and control group accumulated to 1854.4 mm3 and 1462.9 mm3. The tissue absorption, SUV and T/NT of intewention group were (3.56±0.54)%ID/g, 0.70±0.09 and 4.91±0.92(n=5) by 18F-FDG micro-PET,more than the control group which were 3.28%ID/g, 0.60 and 3.98(n=1). The tissue absorption, SUV and T/NT of intervention group were (2.19±0.16)%ID/g, 0.51±0.04 and 4.15±0.57(n=4)by 18F-RGD micro-PET. The tumor weight of two group were (1.93±0.95)g(n=5)and 1.69 g(n=1),so the tumor inhibitory rate was -14.76%. The medium overall survive of intervention group was 60 d, longer than 40.5 d of control group(P<0.05). Conclusion The overall survival time of nude mice bearing HCC treated with Gexia Zhuyutang was prolonged possibly by inhibiting glucose absorption and angiogenesis. Micro-PET imaging technology can dynamically analyze the physiological and biochemical changes in animal models,and it also can be used for evaluating the effect of antitumor drugs in vivo.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!